E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/4/2006 in the Prospect News Biotech Daily.

Small Bone Innovations raises $42.2 million in series B financing

By E. Janene Geiss

Philadelphia, Jan. 4 - Small Bone Innovations, Inc. said it raised $42.2 million in series B financing, the largest venture capital investment ever recorded in the field of orthopedic devices, according to a company news release.

NGN Capital and 3i were the lead investors. Other investors included Anspach Investments, Inc., Axiom Venture Partners III LP, TGap Venture Capital Fund, LP and Viscogliosi Brothers, LLC, as well as Small Bone employees and a select group of individual investors, including leading orthopedic surgeons.

The financing will be used to expand the company's marketing and infrastructure. During the next 18 months, Small Bone expects to double its revenues through new product introductions and small acquisitions, Small Bone chief operating officer Michael Simpson said in the release.

Kenneth S. Abramowitz, a managing general partner of NGN Capital, will join the company's board. John R. Costantino, also a managing general partner of NGN, will hold an observer seat.

Small Bone was founded in 2004 by Viscogliosi Brothers, LLC, a New York-based merchant banking firm specializing in the musculoskeletal/orthopedic sector.

Small Bone was the first company to focus purely on the orthopedic care of arthritis and trauma in small bones and joints.

Viscogliosi Brothers, which led the company's series A financing, invested additional capital as part of the series B round. Anthony G. Viscogliosi will serve as Small Bone's chief executive officer.

The series B round was completed Dec. 12.

Small Bone, based in New York City, has a deep pipeline of implants, fixation and tissue technology products, which will enable it to take advantage of the strong growth in that niche of the orthopedics market.

Issuer:Small Bones Innovations, Inc.
Issue:Series B financing
Amount:$42.2 million
Investors:NGN Capital, 3i (leads), Anspach Investments, Inc., Axiom Venture Partners III LP, TGap Venture Capital Fund, LP, Viscogliosi Brothers, LLC, Small Bone employees, individual investors, orthopedic surgeons
Closing date:Dec. 12

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.